ALK2 inhibitors display beneficial effects in preclinical models of ACVR1 mutant diffuse intrinsic pontine gliomaDiana Carvalho, Chris Jones, Matthew Clarke et al.|Communications Biology|2019Cited by 122
HG-67PRECLINICAL EFFICACY OF ALK2 INHIBITORS IN ACVR1 MUTANT DIPGDiana Carvalho, Chris Jones, Kathryn R. Taylor et al.|Neuro-Oncology|2016Cited by 1